You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 10, October 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  The Cutting Edge: Challenges in Medical and Surgical Therapeutics
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dermatology, Other
 •Alert me on articles by topic

Recombinant Interleukin 2 Monotherapy for Classic Kaposi Sarcoma

Ryo Shibagaki, MD; Saburo Kishimoto, MD; Hideya Takenaka, MD; Hirokazu Yasuno, MD
From the Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

Arch Dermatol. 1998;134:1193-1196.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

REPORT OF A CASE

An 83-year-old Japanese man was referred to our clinic with a 3-year history of multiple cutaneous lesions on both feet, which had slowly increased in size and number. A physical examination revealed scattered blue-red papules up to 5 mm in diameter on both feet, mainly on the soles. The largest dome-shaped nodule (10 mm in diameter) was present on the ventral aspect of his right first toe. The inguinal lymph nodes were not palpable. Results of computed tomographic scanning showed no metastatic lesions in the liver or other abdominal organs. The results of laboratory studies were within normal limits, including urinalysis, CD4+ and CD8+ lymphocyte counts, and CD4/CD8 ratio. Serologic test results for human immunodeficiency virus (HIV) 1 and HIV-2 were negative. The patient had IgG antibodies to cytomegalovirus. He was otherwise healthy except for having hypertension, for . . . [Full Text of this Article]

THERAPEUTIC CHALLENGE

SOLUTION

COMMENT







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.